Yüklüyor......
Hydroxyurea (hydroxycarbamide) for sickle cell disease
BACKGROUND: Sickle cell disease (SCD) is one of the most common inherited diseases worldwide. It is associated with lifelong morbidity and a reduced life expectancy. Hydroxyurea (hydroxycarbamide), an oral chemotherapeutic drug, ameliorates some of the clinical problems of SCD, in particular that of...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2017
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478259/ https://ncbi.nlm.nih.gov/pubmed/28426137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD002202.pub2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|